Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.40    0.40 (0.26%)
Bid:
156.40
Ask:
156.80
Spread: 0.40 (0.256%)
Market Cap: £894.25m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM update

21 Apr 2020 07:00

RNS Number : 2658K
Elementis PLC
21 April 2020
 

AGM 2020 - Update

 

On 25 March 2020, the Company published its Notice of 2020 Annual General Meeting (AGM), a copy of which is available on the Company's website at https://www.elementis.com/agm-information

 

In light of the Government's 'Stay at Home Measures' to deal with the COVID-19 pandemic which prohibit public gatherings and unnecessary travel, the Company is amending the previously announced arrangements for the AGM. In particular shareholders should not attend the meeting in person and are strongly encouraged to vote by proxy as set out below.

 

In normal circumstances, the Board welcomes opportunities to engage with shareholders, including through their attendance and questions at the meeting and regrets that this is not possible in the circumstances. To ensure the safety of employees and shareholders, the Board has put in place the following alternative arrangements:

 

Change of venue/timing:

The AGM will now be held at Elementis' head office at Caroline House, 55-57 High Holborn, London, WC1V 6DX and will allow us to have more flexibility and greater control over proceedings, based on the latest safety advice.

 

The date and time of the meeting remain unchanged as 29 April 2020 at 9.00am.

 

Attendance:

Shareholders must not attend the meeting in person. The minimum number of directors or employees of the Company will attend to ensure that the meeting is quorate. The meeting will be conducted without a presentation or a question and answer session.

 

Any person attempting to attend the AGM in person will be refused admission.

 

Proxy voting:

Shareholders are strongly recommended to complete, sign and return their Form of Proxy to our Registrar, Equiniti, or vote on-line to ensure that their vote still counts despite being unable to attend the meeting in person.

 

Shareholders are also encouraged to appoint the "Chairman of the meeting" as their proxy to vote on their behalf. Proxy instructions should be submitted as soon as possible and must be received by 9.00am (UK time) on Monday 27 April 2020.

 

If you have any questions regarding your shareholding, please contact Equiniti by telephone on 0371 384 2379 (overseas +44 121 415 7043; or for shareholders who have already registered with Equiniti's online portfolio service; Shareview, on the internet at www.shareview.co.uk (lines are open from 8.30am to 5.30pm, Monday to Friday excluding public holidays in England and Wales).

 

Shareholder questions:

Shareholders are encouraged to submit questions prior to the date of the AGM, relating to the business being dealt with at the AGM, to the Company Secretary using the following e-mail address: company.secretariat@elementis.com.

 

The Company will respond to submitted questions following the AGM.

 

The Board will review these arrangements for the AGM and any additional and/or alternative measures in advance of the AGM. The Company will continue to update shareholders on material corporate and business developments in the usual way via the RNS. Further information will be made available at the Company's website. The Company encourages shareholders to continue to monitor the Company's website and announcements for any updates regarding the AGM.

 

Elementis would like to thank all shareholders for their co-operation and understanding in these challenging times.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSESFUSESSEEL
Date   Source Headline
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing
1st Sep 202212:39 pmRNSHolding(s) in Company
1st Sep 20229:15 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.